Swiss Re (VTX:SREN) has been assigned a CHF 87 target price by stock analysts at Sanford C. Bernstein in a report issued on Friday, November 17th. The firm presently has a “neutral” rating on the stock. Sanford C. Bernstein’s price objective suggests a potential downside of 5.84% from the stock’s previous close.
SREN has been the topic of several other research reports. J P Morgan Chase & Co set a CHF 104 target price on Swiss Re and gave the stock a “buy” rating in a research note on Wednesday, September 13th. Barclays set a CHF 88.80 price target on Swiss Re and gave the stock a “neutral” rating in a report on Wednesday, August 30th. Commerzbank set a CHF 87 price objective on Swiss Re and gave the company a “sell” rating in a report on Monday, August 14th. Jefferies Group set a CHF 91 price objective on Swiss Re and gave the company a “neutral” rating in a report on Thursday, August 31st. Finally, Deutsche Bank set a CHF 104 price target on Swiss Re and gave the stock a “buy” rating in a research note on Monday, August 7th. Three analysts have rated the stock with a sell rating, nine have given a hold rating and eight have issued a buy rating to the company’s stock. Swiss Re currently has a consensus rating of “Hold” and an average price target of CHF 95.05.
Swiss Re (VTX:SREN) opened at CHF 92.40 on Friday. Swiss Re has a 12 month low of CHF 81.65 and a 12 month high of CHF 98.50.
Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.
Receive News & Ratings for Swiss Re AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re AG and related companies with MarketBeat.com's FREE daily email newsletter.